Switch to
More onapp

Mangalam Drugs and Organics Ltd

MANGALAM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹180 cr, stock is ranked 1,882
Moderate RiskStock is 2.64x as volatile as Nifty
110.603.45 (-3.02%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹180 cr, stock is ranked 1,882
Moderate RiskStock is 2.64x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
9.19
PB RatioPB Ratio
1.20
Dividend YieldDiv. Yield
Sector PESector PE
34.26
Sector PBSector PB
4.19
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Mangalam Drugs and Organics Limited is engaged in the manufacturing of drugs, medicines and allied products. The Company also manufactures active pharma ingredients (API), intermediates and specialty chemicals.

Financial TrendFinancial statements 

2019202020212022227.90283.53384.70451.16-8.038.2527.9619.65
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Updates 
Announced OnJan 13, 2023

Mangalam Drugs And Organics Limited has informed the Exchange regarding 'Pursuant to Regulation 76 of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find enclosed the Reconciliation of Share Capital Audit Report for the quarter ended December 31, 2022. We request your good office to kindly take the above certificate on record and acknowledge receipt of the same.'. | Download

Mangalam Drugs And Organics Limited has informed the Exchange regarding 'Pursuant to Regulation 76 of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find enclosed the Reconciliation of Share Capital Audit Report for the quarter ended December 31, 2022. We request your good office to kindly take the above certificate on record and acknowledge receipt of the same.'. | Download

Certificate under SEBI (Depositories and Participants) Regulations, 2018 
Announced OnJan 9, 2023

Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Cash Dividend 
Ex. DateDec 21, 2017

Interim • Div/Share: ₹ 0.5

See all events